Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Andrew Yang, Jessica Jeang, Kevin Cheng, Ting Cheng, Benjamin Yang, T.-C. Wu & Chien-Fu Hung. (2016) Current state in the development of candidate therapeutic HPV vaccines. Expert Review of Vaccines 15:8, pages 989-1007.
Read now
Read now
Qun-ying Mao, Yiping Wang, Lianlian Bian, Miao Xu & Zhenglun Liang. (2016) EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Review of Vaccines 15:5, pages 599-606.
Read now
Read now
Articles from other publishers (52)
Yiqing Tang, Cuicui Qiao, Qianqian Li, Xiaodi Zhu, Ronglan Zhao & Xiaoxiang Peng. (2022) Research Progress in the Relationship Between P2X7R and Cervical Cancer. Reproductive Sciences 30:3, pages 823-834.
Crossref
Crossref
Masahiro Kagabu & Tsukasa Baba. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
19
.
Yiting Cai. (2022) Progress of research on human papilloma virus vaccine application. Highlights in Science, Engineering and Technology 19, pages 142-147.
Crossref
Crossref
Parisa Shiri Aghbash, Milad Shirvaliloo, Ammar Khalo Abass Kasho, Farbod Alinezhad, Hans Nauwynck & Hossein Bannazadeh Baghi. (2022) Cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis?. International Immunopharmacology 108, pages 108896.
Crossref
Crossref
Niloofar Khairkhah, Azam Bolhassani & Reza Najafipour. (2022) Current and future direction in treatment of HPV-related cervical disease. Journal of Molecular Medicine 100:6, pages 829-845.
Crossref
Crossref
Prashant Kumar Tiwari, Divya Kushwaha & Ambuj Kumar Kushwaha. 2022. Immunopathology, Diagnosis and Treatment of HPV Induced Malignancies. Immunopathology, Diagnosis and Treatment of HPV Induced Malignancies
43
63
.
Louise Ferrall, Ken Y. Lin, Richard B.S. Roden, Chien-Fu Hung & T.-C. Wu. (2021) Cervical Cancer Immunotherapy: Facts and Hopes. Clinical Cancer Research 27:18, pages 4953-4973.
Crossref
Crossref
Lin Su, Yunwen Zhang, Xiang Zhang, Ting Liu, Sijing Liu, Yongyu Li, Mingjuan Jiang, Tian Tang, Haiqian Shen & Chuan Wang. (2021) Combination immunotherapy with two attenuated Listeria strains carrying shuffled HPV-16 E6E7 protein causes tumor regression in a mouse tumor model. Scientific Reports 11:1.
Crossref
Crossref
Samuel T. Pellom, Claire Smalley Rumfield, Y. Maurice MorillonIIII, Nicholas Roller, Lisa K. Poppe, Douglas E. Brough, Helen Sabzevari, Jeffrey Schlom & Caroline Jochems. (2021) Characterization of recombinant gorilla adenovirus HPV therapeutic vaccine PRGN-2009. JCI Insight 6:7.
Crossref
Crossref
Loredana Sabina Cornelia Manolescu, Cristina Iulia Mitran, Madalina Irina Mitran, Simona Roxana Georgescu, Mircea Tampa, Ioana Suciu, George Suciu, Mãdãlina Preda, Cristiana Cerasella Dragomirescu, Gabriela Loredana Popa, Irina Nita & Mircea Ioan Popa. (2021) KNOWLEDGE, ATTITUDE AND PERCEPTION TOWARDS THE HPV INFECTION AND IMMUNIZATION AMONG ROMANIAN MEDICAL STUDENTS. Romanian Archives of Microbiology and Immunology 80:1, pages 22-34.
Crossref
Crossref
Oscar Badillo-Godinez, Adolfo Pedroza-Saavedra, Veronica Valverde-Garduño, Victor Bermudez-Morales, Minerva Maldonado-Gama, Ricardo Leon-Letelier, Laura C. Bonifaz, Fernando Esquivel-Guadarrama & Lourdes Gutierrez-Xicotencatl. (2021) Induction of Therapeutic Protection in an HPV16-Associated Mouse Tumor Model Through Targeting the Human Papillomavirus-16 E5 Protein to Dendritic Cells. Frontiers in Immunology 12.
Crossref
Crossref
Wei-Liang Shih, Chi-Tai Fang & Pei-Jer Chen. 2021. Viruses and Human Cancer. Viruses and Human Cancer
325
354
.
Rosella Franconi, Silvia Massa, Francesca Paolini, Patrizia Vici & Aldo Venuti. (2020) Plant-Derived Natural Compounds in Genetic Vaccination and Therapy for HPV-Associated Cancers. Cancers 12:11, pages 3101.
Crossref
Crossref
Fabio Barra, Luigi Della Corte, Giovanni Noberasco, Virginia Foreste, Gaetano Riemma, Claudia Di Filippo, Giuseppe Bifulco, Andrea Orsi, Giancarlo Icardi & Simone Ferrero. (2020) Advances in therapeutic vaccines for treating human papillomavirus‐related cervical intraepithelial neoplasia. Journal of Obstetrics and Gynaecology Research 46:7, pages 989-1006.
Crossref
Crossref
M. S. Vonsky, A. L. Runov, I. V. Gordeychuk & M. G. Isaguliants. (2019) Therapeutic Vaccines Against Human Papilloma Viruses: Achievements and Prospects. Biochemistry (Moscow) 84:7, pages 800-816.
Crossref
Crossref
Samir A. Farghaly. 2019. Uterine Cervical Cancer. Uterine Cervical Cancer
107
140
.
Jin Qiu, Shiwen Peng, Ying Ma, Andrew Yang, Emily Farmer, Max A. Cheng, Richard B.S. Roden, T.-C. Wu, Yung-Nien Chang & Chien-Fu Hung. (2018) Epithelial boost enhances antigen expression by vaccinia virus for the generation of potent CD8+ T cell-mediated antitumor immunity following DNA priming vaccination. Virology 525, pages 205-215.
Crossref
Crossref
Maryam Dadar, Sandip Chakraborty, Kuldeep Dhama, Minakshi Prasad, Rekha Khandia, Sameer Hassan, Ashok Munjal, Ruchi Tiwari, Kumaragurubaran Karthik, Deepak Kumar, Hafiz M. N. Iqbal & Wanpen Chaicumpa. (2018) Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus. Frontiers in Immunology 9.
Crossref
Crossref
Max A. ChengEmily FarmerClaire HuangJohn LinChien-Fu HungT.-C. Wu. (2018) Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases. Human Gene Therapy 29:9, pages 971-996.
Crossref
Crossref
Jianqiang Li, Si Chen, Jun Ge, Feng Lu, Sulin Ren, Zhiqiang Zhao, Xiuying Pu, Xiaoxiao Chen, Jiaojiao Sun & Yueqing Gu. (2017) A novel therapeutic vaccine composed of a rearranged human papillomavirus type 16 E6/E7 fusion protein and Fms-like tyrosine kinase-3 ligand induces CD8+ T cell responses and antitumor effect. Vaccine 35:47, pages 6459-6467.
Crossref
Crossref
Carlos Rosales & Ricardo Rosales. 2017. Vaccines. Vaccines.
Jole Ventriglia, Immacolata Paciolla, Carmela Pisano, Sabrina Chiara Cecere, Marilena Di Napoli, Rosa Tambaro, Daniela Califano, Simona Losito, Giosuè Scognamiglio, Sergio Venanzio Setola, Laura Arenare, Sandro Pignata & Chiara Della Pepa. (2017) Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives. Cancer Treatment Reviews 59, pages 109-116.
Crossref
Crossref
Nazila Ghorban HosseiniMajid TebianianAyoub FarhadiAli Hossein khaniArian RahimiMojtaba MortazaviSeyed Younes HosseiniMorteza TaghizadehMahsa RezaeiMehdi Mahdavi. (2017)
In Silico
Analysis of L1/L2 Sequences of Human Papillomaviruses: Implication for Universal Vaccine Design
. Viral Immunology 30:3, pages 210-223.
Crossref
Crossref
Andrew Yang, Emily Farmer, John Lin, T.-C. Wu & Chien-Fu Hung. (2017) The current state of therapeutic and T cell-based vaccines against human papillomaviruses. Virus Research 231, pages 148-165.
Crossref
Crossref
Gaurav Gupta, Reinhard Glueck & Narayan Rishi. (2017) Physicochemical characterization and immunological properties of Pichia pastoris based HPV16L1 and 18L1 virus like particles. Biologicals 46, pages 11-22.
Crossref
Crossref
Ming-Chieh Yang, Andrew Yang, Jin Qiu, Benjamin Yang, Liangmei He, Ya-Chea Tsai, Jessica Jeang, T.-C. Wu & Chien-Fu Hung. (2016) Buccal injection of synthetic HPV long peptide vaccine induces local and systemic antigen-specific CD8+ T-cell immune responses and antitumor effects without adjuvant. Cell & Bioscience 6:1.
Crossref
Crossref
Andrew Yang, Emily Farmer, T. C. Wu & Chien-Fu Hung. (2016) Perspectives for therapeutic HPV vaccine development. Journal of Biomedical Science 23:1.
Crossref
Crossref
Felix A. Mensah, Mudresh R. Mehta, James S. LewisJr.Jr. & A. Craig Lockhart. (2016) The Human Papillomavirus Vaccine: Current Perspective and Future Role in Prevention and Treatment of Anal Intraepithelial Neoplasia and Anal Cancer. The Oncologist 21:4, pages 453-460.
Crossref
Crossref
Dmitriy Zamarin & Amir A. Jazaeri. (2016) Leveraging immunotherapy for the treatment of gynecologic cancers in the era of precision medicine. Gynecologic Oncology 141:1, pages 86-94.
Crossref
Crossref
Sung-Jong Lee, Andrew Yang, T.-C. Wu & Chien-Fu Hung. (2016) Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research. Journal of Gynecologic Oncology 27:5.
Crossref
Crossref
Peter M. Moyle, Wei Dai, Tzu-Yu Liu, Waleed M. Hussein, Pirashanthini Maruthayanar, James W. Wells, Nigel A.J. McMillan, Mariusz Skwarczynski & Istvan Toth. (2015) Combined synthetic and recombinant techniques for the development of lipoprotein-based, self-adjuvanting vaccines targeting human papillomavirus type-16 associated tumors. Bioorganic & Medicinal Chemistry Letters 25:23, pages 5570-5575.
Crossref
Crossref
Anoop Kumar, Showket Hussain, Gagan Sharma, Ravi Mehrotra, Lutz Gissmann, Bhudev C. Das & Mausumi Bharadwaj. (2015) Identification and validation of immunogenic potential of India specific HPV-16 variant constructs: In-silico & in-vivo insight to vaccine development. Scientific Reports 5:1.
Crossref
Crossref
Aldo Venuti, Gianfranca Curzio, Luciano Mariani & Francesca Paolini. (2015) Immunotherapy of HPV-associated cancer: DNA/plant-derived vaccines and new orthotopic mouse models. Cancer Immunology, Immunotherapy 64:10, pages 1329-1338.
Crossref
Crossref
Sonia Whang, Maria Filippova & Penelope Duerksen-Hughes. (2015) Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck Cancer. Viruses 7:9, pages 5040-5065.
Crossref
Crossref
Tina Dalianis. 2015. Viral Nanotechnology. Viral Nanotechnology
295
302
.
Hee-Jung Lee, Jong Kwang Yoon, Yoonki Heo, Hansam Cho, Yeondong Cho, Yongdae Gwon, Kang Chang Kim, Jiwon Choi, Jae Sung Lee, Yu-Kyoung Oh & Young Bong Kim. (2015) Therapeutic potential of an AcHERV-HPV L1 DNA vaccine. Journal of Microbiology 53:6, pages 415-420.
Crossref
Crossref
Frank R. Jones, Elizabeth S. Gabitzsch & Joseph P. Balint. The Ad5 [E1-, E2b-]-based vector: a new and versatile gene delivery platform. The Ad5 [E1-, E2b-]-based vector: a new and versatile gene delivery platform.
John T Schiller & Martin Müller. (2015) Next generation prophylactic human papillomavirus vaccines. The Lancet Oncology 16:5, pages e217-e225.
Crossref
Crossref
Sushil Kumar, Manash Biswas & Tony Jose. (2015) HPV vaccine: Current status and future directions. Medical Journal Armed Forces India 71:2, pages 171-177.
Crossref
Crossref
Sima Rahimian, Marieke F. Fransen, Jan Willem Kleinovink, Jonatan Riis Christensen, Maryam Amidi, Wim E. Hennink & Ferry Ossendorp. (2015) Polymeric nanoparticles for co-delivery of synthetic long peptide antigen and poly IC as therapeutic cancer vaccine formulation. Journal of Controlled Release 203, pages 16-22.
Crossref
Crossref
Sara J. McKee, Anne-Sophie Bergot & Graham R. Leggatt. (2015) Recent progress in vaccination against human papillomavirus-mediated cervical cancer. Reviews in Medical Virology 25, pages 54-71.
Crossref
Crossref
Yong-Hee Kim. (2015) Current and Next-generation Vaccines against Human Papillomaviruses. Journal of Bacteriology and Virology 45:3, pages 189.
Crossref
Crossref
Donatella Panatto, Daniela Amicizia, Nicola Luigi Bragazzi, Emanuela Rizzitelli, Daniela Tramalloni, Ivana Valle & Roberto Gasparini. 2015.
231
322
.
Sun M. Ahn & Nishant Agrawal. 2015. Genomic Applications in Pathology. Genomic Applications in Pathology
341
358
.
Alireza Tahamtan, Amir Ghaemi, Ali Gorji, Hamid R Kalhor, Azadeh Sajadian, Alijan Tabarraei, Abdolvahab Moradi, Fatemeh Atyabi & Mishar Kelishadi. (2014) Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems. Journal of Biomedical Science 21:1.
Crossref
Crossref
Patrizia Vici, Luciano Mariani, Laura Pizzuti, Domenico Sergi, Luigi Di Lauro, Enrico Vizza, Federica Tomao, Silverio Tomao, Claudia Cavallotti, Francesca Paolini & Aldo Venuti. (2014) Immunologic treatments for precancerous lesions and uterine cervical cancer. Journal of Experimental & Clinical Cancer Research 33:1.
Crossref
Crossref
Mark Whitehead, Peter Öhlschläger, Fahad N Almajhdi, Leonor Alloza, Pablo Marzábal, Ann E Meyers, Inga I Hitzeroth & Edward P Rybicki. (2014) Human papillomavirus (HPV) type 16 E7 protein bodies cause tumour regression in mice. BMC Cancer 14:1.
Crossref
Crossref
Dorien Van hede, Inge Langers, Philippe Delvenne & Nathalie Jacobs. (2014) Origin and immunoescape of uterine cervical cancer. La Presse Médicale 43:12, pages e413-e421.
Crossref
Crossref
Hiromasa Okayasu, Roland W. Sutter, Hamid S. Jafari, Marina Takane & R. Bruce Aylward. (2014) Affordable Inactivated Poliovirus Vaccine: Strategies and Progress. The Journal of Infectious Diseases 210:suppl_1, pages S459-S464.
Crossref
Crossref
Erika Wissinger, Ingolf Griebsch, Juliane Lungershausen, Talia Foster & Chris L. Pashos. (2014) The Economic Burden of Head and Neck Cancer: A Systematic Literature Review. PharmacoEconomics 32:9, pages 865-882.
Crossref
Crossref
Monika E. Freiser, Paolo Serafini & Donald T. Weed. (2013) The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities. Immunologic Research 57:1-3, pages 52-69.
Crossref
Crossref
Ayesha Mirza & Mobeen H. Rathore. (2013) Immunization Update IV. Advances in Pediatrics 60:1, pages 11-31.
Crossref
Crossref